Ironwood Pharmaceuticals
IRWD
IRWD
200 hedge funds and large institutions have $229M invested in Ironwood Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 74 increasing their positions, 63 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 223 → 200 (-23)
43% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 51
69% less capital invested
Capital invested by funds: $727M → $229M (-$499M)
Holders
200
Holding in Top 10
1
Calls
$16.5M
Puts
$10K
Top Buyers
| 1 | +$10.1M | |
| 2 | +$9.95M | |
| 3 | +$7.37M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$7.26M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$5.07M |
Top Sellers
| 1 | -$26.6M | |
| 2 | -$23.7M | |
| 3 | -$11.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.15M |
| 5 |
Morgan Stanley
New York
|
-$5.15M |